Regulatory risk and strategic reshuffling shape major deal activity

Summary

Three Democratic senators asked the FCC to prevent Paramount Skydance from closing a $111 billion merger with Warner Bros. Discovery until a national security review of foreign investors is completed. The request was made in a June 18 letter to FCC Chairman Brendan Carr.

Why it matters

When national security review enters the critical path, merger certainty drops and the economics of large media consolidation can change fast.

Summary

AbbVie is nearing a deal of almost $11 billion to acquire Apogee Therapeutics. The move comes as large pharmaceutical companies increase biotech acquisitions to refill drug pipelines.

Why it matters

Big-ticket biotech deals reset valuations and signal how aggressively pharma will pay to de-risk future revenue gaps.

Summary

Pollen Street plans to acquire Finastra’s global core banking software unit, Universal Banking, and run it as a standalone business. The buyer says it will invest to speed product innovation, strengthen customer delivery, and expand capabilities, subject to regulatory approvals.

Why it matters

Core banking ownership changes can alter product roadmaps, pricing, and risk posture for banks, while signaling where major fintech vendors see the next profit pool.

Summary

Finastra agreed to sell its Universal Banking global core banking software business to private equity firm Pollen Street Capital. The companies did not disclose financial terms.

Why it matters

Core banking is sticky infrastructure, so a change in control can quickly reshape product roadmaps, customer costs, and competitive dynamics across bank tech stacks.